Although private equity investment in U.S. cannabis companies is down this year as fund managers grapple with federal opposition to legalization and banks remain wary of getting involved, attorneys must be ready to advise on pot-related deals because the drought is destined to end. Brett Schuman and Bill Growney, partners at Goodwin and co-chairs of the firm's Cannabis practice, told Law360 the private equity cannabis stats may be somewhat misleading. From their point of view, the market for cannabis-related investments of all stripes is continuing to grow, even though marijuana remains federally outlawed. Read the article here.